Literature DB >> 12727802

Characterization of the rat aflatoxin B1 aldehyde reductase gene, AKR7A1. Structure and chromosomal localization of AKR7A1 as well as identification of antioxidant response elements in the gene promoter.

Elizabeth M Ellis1, Cara M Slattery, John D Hayes.   

Abstract

Rat aflatoxin B(1) aldehyde reductase (called AFAR1 or AKR7A1) is a member of the aldo-keto reductase 7 family, which metabolizes the environmental carcinogen aflatoxin B(1). The expression of this enzyme is markedly increased in rat liver by cancer chemopreventive agents, many of which are believed to regulate gene expression through the antioxidant response element (ARE). In order to understand how this gene is regulated, two overlapping genomic clones have been isolated that contain most of the coding region for the enzyme; together they encompass 14.1 kb of DNA. Characterization of these clones has shown that rat AFAR1 is approximately 8 kb long and comprises seven exons and six introns. The seven exons are between 97 and 380 bp in size. The introns range in size from 194 bp to approximately 2.9 kb. Fluorescent in situ hybridization localized AFAR1 to rat chromosome 5q36.5, a region that is syntenic with human chromosome 1p35-1p36.1 where AKR7A2 resides. The transcriptional start site (TSS) was determined, using 5'-rapid amplification of cDNA ends, to be an A nucleotide 73 bp upstream from the ATG initiation codon. The 5'-flanking region of AFAR1 was isolated by polymerase chain reaction-based genome walking, and resulted in the isolation of approximately 900 bp of genomic DNA upstream from the TSS. Use of a gene expression reporter assay demonstrated that this cloned 5'-flanking region of AFAR1 could support transcription in the rat liver 34 (RL34) epithelial cell line. Within this upstream region of the promoter, a substantial number of sequences were found that are closely similar, but not identical, to the 'core' ARE consensus sequence. Between nucleotides -810 and -106 bp from the TSS 16 ARE-related sequences were identified. Four of these putative enhancers lay between -389 and -355 bp, and the motif 5'-GAGTGAG-3' was repeated three times within the 35 bp region.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727802     DOI: 10.1093/carcin/bgg016

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

1.  Expression of Nrf2 and its downstream gene targets in hibernating 13-lined ground squirrels, Spermophilus tridecemlineatus.

Authors:  Pier Morin; Zhouli Ni; David C McMullen; Kenneth B Storey
Journal:  Mol Cell Biochem       Date:  2008-03-10       Impact factor: 3.396

2.  Aldo-Keto Reductase Regulation by the Nrf2 System: Implications for Stress Response, Chemotherapy Drug Resistance, and Carcinogenesis.

Authors:  Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2016-11-16       Impact factor: 3.739

3.  Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver.

Authors:  Neil R Kitteringham; Azman Abdullah; Joanne Walsh; Laura Randle; Rosalind E Jenkins; Rowena Sison; Christopher E P Goldring; Helen Powell; Christopher Sanderson; Samantha Williams; Larry Higgins; Masayuki Yamamoto; John Hayes; B Kevin Park
Journal:  J Proteomics       Date:  2010-04-24       Impact factor: 4.044

4.  Isoenzyme-specific up-regulation of glutathione transferase and aldo-keto reductase mRNA expression by dietary quercetin in rat liver.

Authors:  Tseye-Oidov Odbayar; Toshinori Kimura; Tojiro Tsushida; Takashi Ide
Journal:  Mol Cell Biochem       Date:  2009-02-04       Impact factor: 3.396

5.  Dealing with aflatoxin B1 dihydrodiol acute effects: Impact of aflatoxin B1-aldehyde reductase enzyme activity in poultry species tolerant to AFB1 toxic effects.

Authors:  Hansen Murcia; Gonzalo J Diaz
Journal:  PLoS One       Date:  2020-06-22       Impact factor: 3.240

6.  De novo Transcriptome of the Non-saxitoxin Producing Alexandrium tamutum Reveals New Insights on Harmful Dinoflagellates.

Authors:  Giorgio Maria Vingiani; Dārta Štālberga; Pasquale De Luca; Adrianna Ianora; Daniele De Luca; Chiara Lauritano
Journal:  Mar Drugs       Date:  2020-07-24       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.